| Stage | LIN | % of rev | KRO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.4B | 100.00% | $558M | 100.00% | LIN ×16.85 |
| Gross profit | $4.4B | 47.24% | $103M | 18.42% | LIN +28.8pp |
| Operating income | $2.1B | 22.86% | $38M | 6.74% | LIN +16.1pp |
| Pre-tax income | $2.1B | 22.63% | $23M | 4.10% | LIN +18.5pp |
| Net income | $1.7B | 18.50% | $15M | 2.72% | LIN +15.8pp |
| Stage | LIN | KRO | Gap · A − B |
|---|---|---|---|
| Revenue | $9.4B100.00% | $558M100.00% | LIN ×16.85 |
| Gross profit | 47.24%$4.4B | 18.42%$103M | LIN +28.8pp |
| Operating income | 22.86%$2.1B | 6.74%$38M | LIN +16.1pp |
| Pre-tax income | 22.63%$2.1B | 4.10%$23M | LIN +18.5pp |
| Net income |
| 18.50%$1.7B |
| 2.72%$15M |
| LIN +15.8pp |